ITPR3

Chr 6AD

inositol 1,4,5-trisphosphate receptor type 3

Also known as: CMT1J, IMD132, IMD133, IP3R, IP3R-3, IP3R3

This gene encodes a receptor for inositol 1,4,5-trisphosphate, a second messenger that mediates the release of intracellular calcium. The receptor contains a calcium channel at the C-terminus and the ligand-binding site at the N-terminus. Knockout studies in mice suggest that type 2 and type 3 inositol 1,4,5-trisphosphate receptors play a key role in exocrine secretion underlying energy metabolism and growth. [provided by RefSeq, Aug 2010]

OMIMResearchGenerating clinical summary…
DNmechanismADLOEUF 0.572 OMIM phenotypes
Clinical SummaryITPR3
🧬
Gene-Disease Validity (ClinGen)
Charcot-Marie-Tooth disease, demyelinating, type 1J · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
6 unique Pathogenic / Likely Pathogenic· 404 VUS of 706 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint?
0.57LOEUF
pLI 0.000
Z-score 5.70
OE 0.46 (0.370.57)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
4.55Z-score
OE missense 0.69 (0.650.72)
1144 obs / 1667.0 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.46 (0.370.57)
00.351.4
Missense OE?0.69 (0.650.72)
00.61.4
Synonymous OE?0.92
01.21.6
LoF obs/exp: 59 / 128.8Missense obs/exp: 1144 / 1667.0Syn Z: 1.69
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
moderateITPR3-related immunodeficiency with ectodermal dysplasia with or without peripheral neuropathyDNAD

This gene — mechanism propensity

DN
0.6745th %ile
GOF
0.6931th %ile
LOF
0.3355th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports dominant-negative. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median · 1 literature citation
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNDominant mutations in ITPR3 cause Charcot-Marie-Tooth disease. Trio exome sequencing identified a de novo ITPR3 variant p.Arg2524Cys. Altered Ca2+ -transients in p.Val615Met patient fibroblasts suggested that the variant has a dominant-negative effect on inositol 1,4,5-trisphosphate receptor type 3 1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 32949214

ClinVar Variant Classifications

706 submitted variants in ClinVar

Classification Summary

Pathogenic3
Likely Pathogenic3
VUS404
Likely Benign82
Benign147
Conflicting8
3
Pathogenic
3
Likely Pathogenic
404
VUS
82
Likely Benign
147
Benign
8
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
3
0
0
3
Likely Pathogenic
1
2
0
0
3
VUS
9
390
3
2
404
Likely Benign
0
12
15
55
82
Benign
0
6
111
30
147
Conflicting
8
Total1041312987647

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

6 pathogenic / likely-pathogenic (of 10) ClinVar copy-number / structural variants overlap ITPR3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ITPR3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →